Hepatitis B-Induced Immunological Remodeling in Hepatocellular Carcinoma
MEDS Clinical Medicine · 2026 · 7 (2)
DOI: 10.23977/medsc.2026.070210 ↗Kurz gefasst
Fachartikel in der Zeitschrift MEDS Clinical Medicine, 2026.
Abstract (Originalsprache)
Persistent infection with Hepatitis B virus (HBV) for more than six months can lead to chronic hepatitis B (CHB), which is a major cause of Hepatocellular carcinoma (HCC). Chronic HBV infection continuously damages the liver and promotes the formation of an immunosuppressive and inflammatory hepatic microenvironment, but the mechanisms linking hepatocyte alterations to immune dysfunction during disease progression remain incompletely understood. This review focuses on how chronic HBV infection reprograms hepatocytes and reshapes the hepatic immune microenvironment during the transition from CHB to HCC. We propose that epigenetic alterations and metabolic rewiring are two interconnected mechanisms driving this process. These changes regulate gene expression, signaling pathways, and metabolite production in hepatocytes, thereby influencing cytokine and metabolite release that promotes immune cell dysfunction and immune suppression. Overall, we highlights the mechanistic connection between hepatocyte reprogramming and immune microenvironment remodeling in HBV-related hepatocarcinogenesis, and discusses potential therapeutic targets for HBV-associated HCC.
Zitieren
APA
(2026). Hepatitis B-Induced Immunological Remodeling in Hepatocellular Carcinoma. MEDS Clinical Medicine, 7(2). https://doi.org/10.23977/medsc.2026.070210
Vancouver
Hepatitis B-Induced Immunological Remodeling in Hepatocellular Carcinoma. MEDS Clinical Medicine. 2026;7(2). doi:10.23977/medsc.2026.070210
BibTeX
@article{euvimed2026,
title = {Hepatitis B-Induced Immunological Remodeling in Hepatocellular Carcinoma},
journal = {MEDS Clinical Medicine},
year = {2026},
volume = {7},
number = {2},
doi = {10.23977/medsc.2026.070210}
}
EUVIMED